Glaukos Corp Files 8-K for Regulatory Disclosures

Ticker: GKOS · Form: 8-K · Filed: May 20, 2024 · CIK: 1192448

Sentiment: neutral

Topics: regulatory-filing, sec-disclosure

Related Tickers: GKOS

TL;DR

Glaukos filed an 8-K, standard procedure, no major news.

AI Summary

Glaukos Corporation filed an 8-K on May 20, 2024, to report on Regulation FD disclosures and file financial statements and exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.

Why It Matters

This filing indicates Glaukos is adhering to its reporting obligations with the SEC, providing transparency to investors about its corporate actions and financial status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for regulatory compliance and does not disclose any new material adverse information.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Glaukos Corporation?

The primary purpose is to report on Regulation FD disclosures and to file financial statements and exhibits as required by the SEC.

On what date was the earliest event reported in this filing?

The earliest event reported was on May 20, 2024.

In which state was Glaukos Corporation incorporated?

Glaukos Corporation was incorporated in Delaware.

What is the Commission File Number for Glaukos Corporation?

The Commission File Number for Glaukos Corporation is 001-37463.

Where are Glaukos Corporation's principal executive offices located?

Glaukos Corporation's principal executive offices are located in Aliso Viejo, California.

Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-05-20 07:00:48

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 99.1 Investor Presentation, dated May 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLAUKOS CORPORATION (Registrant) By: /s/ Alex R. Thurman Name: Alex R. Thurman Title: Senior Vice President & Chief Financial Officer Date: May 20, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing